Add ANI As A Trusted Source For Reliable Information
Search For "improve patient compliance"
Updated : 5 years, 10 months ago IST
Mumbai (Maharashtra) [India], Aug 6 (ANI): Glenmark Pharmaceuticals will introduce a 400 mg version of oral anti-viral FabiFlu for the treatment of mild to moderate Covid-19 in India.